3SBio Inc Shs Unitary 144A/Reg S 01530
Trading Information
- Previous Close Price
- HKD 6.58
- Day Range
- HKD 6.44–6.92
- 52-Week Range
- HKD 4.91–8.10
- Bid/Ask
- HKD 6.80 / HKD 6.81
- Market Cap
- HKD 16.58 Bil
- Volume/Avg
- 13.8 Mil / 18.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 7.92
- Price/Sales
- 1.92
- Dividend Yield (Trailing)
- 1.47%
- Dividend Yield (Forward)
- 3.68%
- Total Yield
- 1.47%
Company Profile
3SBio Inc, or 3SBio is a biotechnology company. As a pioneer in the Chinese biotechnology industry, the Group has extensive expertise in researching, developing, manufacturing, and marketing biopharmaceuticals. The core products of the Group include several biopharmaceutical drugs, TPIAO recombinant human erythropoietin rhEPO products EPIAO and SEPO, Yisaipu, Cipterbin, and a small molecule drug, Mandi. Except for minoxidil, an over-the-counter drug, the others are all older-generation biologics. The majority of its pipeline candidates are "me-too" drugs and in general, are still at an early stage.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Value
- Total Number of Employees
- 5,411
- Website
- https://www.3sbio.com
Comparables
Valuation
|
Metric
|
01530
|
01167
|
02616
|
|---|---|---|---|
Price/Earnings (Normalized) | 7.92 | — | — |
Price/Book Value | 1.05 | 1.45 | — |
Price/Sales | 1.92 | 20.45 | 2.71 |
Price/Cash Flow | 7.07 | — | — |
Price/Earnings
01530
01167
02616
Financial Strength
|
Metric
|
01530
|
01167
|
02616
|
|---|---|---|---|
Quick Ratio | 2.20 | 5.67 | 1.42 |
Current Ratio | 2.47 | 5.70 | 1.56 |
Interest Coverage | 9.60 | −47.87 | −32.18 |
Quick Ratio
01530
01167
02616
Profitability
|
Metric
|
01530
|
01167
|
02616
|
|---|---|---|---|
Return on Assets (Normalized) | 7.98% | −22.98% | −38.51% |
Return on Equity (Normalized) | 13.60% | −33.40% | −157.15% |
Return on Invested Capital (Normalized) | 9.06% | −28.24% | −69.17% |
Return on Assets
01530
01167
02616
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Pslpdzdvs | Wkv | $545.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Fhmfybxj | Dnlvww | $105.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Fqyhqphvt | Kxfpt | $103.7 Bil | |
MRNA
| Moderna Inc | Fkwrmbfb | Yvmr | $47.9 Bil | |
ARGX
| argenx SE ADR | Pdydbvskr | Pdfl | $22.9 Bil | |
BNTX
| BioNTech SE ADR | Kshrscq | Zcp | $22.3 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Shgmjsds | Mbvvfd | $19.3 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Tpfxwmjp | Ygbpkpy | $15.7 Bil | |
RPRX
| Royalty Pharma PLC Class A | Fffttycn | Rsmpszt | $12.8 Bil | |
INCY
| Incyte Corp | Xtzgsmvsc | Yqqfhz | $12.1 Bil |